Andere Sprachen Ocean Biomedical, Inc.

Aktien

A3D2GJ

US67644C1045

OCEA

Verzögert Nasdaq Andere Börsenplätze 15:56:47 18.06.2024			% 5 Tage	% 1. Jan.
1,51 ^USD	-3,20 %		-5,62 %	+128,80 %

30.05.	Ocean Biomedical erhält Nasdaq-Noncompliance-Bescheid; Aktien fallen	MT
15.04.	Ocean Biomedical, Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positive Immunogenicity Results from Their Lead Checkpoint Modifier-Containing Immunotherapy, VRON-0200, for HBV Functional Cure, at EASL 2024	05.06.
Ocean Biomedical Gets Nasdaq Noncompliance Notice; Shares Down	30.05.
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q	30.05.
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease	16.05.
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K	24.04.
Ocean Biomedical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15.04.
Ocean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASL	28.03.
Ocean Biomedical, Inc. Appoints Amy Griffith as Director	08.03.
Ocean Biomedical, Inc. Announces CFO Changes	04.03.
Ocean Biomedical (NASDAQ: OCEA) Announces Joint Venture Partner, Virion Therapeutics to Present Their First Clinical Study Data as an Accepted Late Breaker Presentation at 2024 APASL Global Liver Meeting	29.02.
Stocks Making Waves: Insights into Key Developments and Potential VTAK, TBIO, OCEA, ONMD, KZIA	27.02.
North American Morning Briefing : S&P 500 Futures -2-	23.02.
North American Morning Briefing : Central Bankers -2-	17.01.
North American Morning Briefing : Stocks to -2-	10.01.
North American Morning Briefing : Stock Futures Extend Losses as FOMC Minutes Awaited	03.01.
North American Morning Briefing : S&P 500 Futures Dip with Fresh Record in Sight	20.12.
North American Morning Briefing : Traders Await -2-	13.12.
Ocean Biomedical, Inc. Announces Publication of Groundbreaking Breast Cancer Research Uncovering a New Tumor Suppression Pathway for Its Proprietary Anti-Chi3L1 Antibody	05.12.
Ocean Biomedical Announces Publication of Breast Cancer Research Uncovering New Tumor Suppression Pathway for its Proprietary Anti-Chi3L1 Antibody	05.12.
Ocean Biomedical Receives Non-Compliance Notice From Nasdaq	30.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Ocean Biomedical, Inc.

Aktien

A3D2GJ

US67644C1045

OCEA

Andere Sprachen

Filter